Walgreens has received $25 million in federal funding to conduct a decentralized clinical trial on COVID-19 vaccine immunity.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
HHS, Walgreens partner on 1st decentralized COVID shot trial
